CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model

Open access
He, Feng, Chou, C. James, Scheiner, Matthias, Poeta, Eleonora, Yuan Chen, Natalia, Gunesch, Sandra, Hoffmann, Matthias, Sotriffer, Christoph, Monti, Barbara, Maurice, Tangui, Decker, Michael · 2021 · Journal of Medicinal Chemistry

Abstract

The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative diseases to incorporate antioxidant effects without losing affinity and selectivity at HDAC6. Structure-activity relationships led to compound 10b as a hybrid molecule showing pronounced and selective inhibition of HDAC6 (IC50 = 30.7 nM, > 25-fold selectivity over other subtypes). This compound shows comparable DPPH radical scavenging ability to ferulic acid, comparable ORAC value to melatonin and comparable Cu 2+ chelating ability to EDTA. It also lacks neurotoxicity on HT-22 cells, exhibits a pronounced immunomodulatory effect, and is active in vivo showing significantly higher efficacy in an AD mouse model to prevent both Aβ25−35-induced spatial working and long-term memory dysfunction at lower dose (0.3 mg/kg) compared to positive control HDAC6 inhibitor ACY1215 and an equimolar mixture of the three entities ACY1215, melatonin and ferulic acid, suggesting potentially disease-modifying properties.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.0c01940

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 65 references

Cited by

See all 71

Metadata

Authors
He, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., & Decker, M.
Affiliations
  • University of Würzburg (DE)
  • Medical University of South Carolina (US)
  • University of Bologna (IT)
  • Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany
  • Inserm (FR)
Corresponding author
  • Maurice, Tangui
  • Decker, Michael
Venue
Journal of Medicinal Chemistry
Published
2021-03-26
Volume
64
Issue
7
Pages
3794-3812
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3136159689
Cited by
66
References
65
Citations by year
2026: 5 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 14 · 2021: 9
FWCI
4.16
Type
journal article
Language
en
Open access
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
Funders
  • Bundesministerium f?r Bildung und Forschung (57387204)
  • Deutscher Akademischer Austauschdienst
  • Campus France
  • Deutsche Forschungsgemeinschaft (DE1546/6-3)
  • Studienstiftung des Deutschen Volkes
  • Bayerisch-Franz?sisches Hochschulzentrum (FK03-2020)
  • China Scholarship Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
HDAC6 inhibitors, melatonin, ferulic acid, Alzheimer's disease, immunomodulation, neuroprotection, antioxidant activity, amyloid beta 25-35, spatial working memory, long-term memory, disease-modifying therapy, structure-activity relationship, HT22 cells
MeSH terms
Histone Deacetylase 6, Alzheimer Disease, Animals, Cell Line, Transformed, Coumaric Acids, Immunologic Factors, Male, Melatonin, Structure-Activity Relationship, Tryptamines, Neuroprotective Agents, Catalytic Domain, Mice, Histone Deacetylase Inhibitors, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model. https://app.cochat.ai/papers/10.1021/acs.jmedchem.0c01940
The paper
He, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., & Decker, M. (2021). Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.0c01940

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.